fr
Article scientifique
Revue de la littérature
Accès libre
Anglais

Highlights and recent developments in allergic diseases in EAACI journals (2019)

Publié dansClinical and Translational Allergy, vol. 10, no. 1, 56
Date de publication2020
Résumé

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2019 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidities, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and meta-analyses have been the highlights of the last year.

Mots-clés
  • Asthma
  • Rhinitis
  • Atopic dermatitis
  • Urticaria
  • Anaphylaxis
  • Food allergy
  • Angioedema
  • Allergens
  • Immunotherapy
  • EAACI
Citation (format ISO)
BOUSQUET, J et al. Highlights and recent developments in allergic diseases in EAACI journals (2019). In: Clinical and Translational Allergy, 2020, vol. 10, n° 1, p. 56. doi: 10.1186/s13601-020-00366-3
Fichiers principaux (1)
Article (Published version)
Identifiants
ISSN du journal2045-7022
87vues
50téléchargements

Informations techniques

Création16.09.2021 15:15:00
Première validation16.09.2021 15:15:00
Heure de mise à jour16.03.2023 02:17:00
Changement de statut16.03.2023 02:17:00
Dernière indexation12.02.2024 12:17:48
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack